Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
CH0008702190
Wed, 28.02.2024
Cicor Technologies Ltd
Bronschhofen, February 28, 2024 - The Cicor Group (SIX Swiss Exchange: CICN) has acquired 100% of the shares of the Romanian engineering company Evolution Medtec Srl and is further expanding its engineering capabilities in the medical technology sector.
Evolution Medtec is a provider of comprehensive engineering services with a strong focus on medi [ … ]
Wed, 24.01.2024
Cicor Technologies Ltd
Cicor Technologies Ltd
/ Key word(s): Mergers & Acquisitions
Cicor successfully closes the acquisition of STS Defence Limited and expands its presence in the UK high-end electronics market 24.01.2024 / 07:00 CET/CEST
Bronschhofen, January 24, 2024 – The Cicor Group (SIX Swiss Exchange: CICN) has successfully closed the acq [ … ]
Mon, 04.12.2023
Cicor Technologies Ltd
Bronschhofen, December 4, 2023 – The Cicor Group (SIX Swiss Exchange: CICN) is publishing its financial mid-term targets for the next three to four years today and hosts its Capital Markets Event 2023 this evening in Zurich.
At the Capital Markets Event, Cicor will provide insights into its growth strategy, value creation through acquisitions, the [ … ]
Tue, 31.10.2023
Cicor Technologies Ltd
Bronschhofen, October 31, 2023 – Benefitting from the current market environment and to provide greater flexibility for day-to-day operations and further growth, Cicor Group (SIX Swiss Exchange: CICN) has signed a credit agreement on October 30, 2023 to refinance the existing portfolio and increase it to CHF 245 million.
Cicor's existing syndicated [ … ]
Wed, 18.10.2023
Cicor Technologies Ltd
Bronschhofen, October 18, 2023 – The Cicor Group (SIX Swiss Exchange: CICN) has signed an agreement to acquire 100% of the shares of UK-based STS Defence Limited (STS Defence).
Cicor is one of Europe's fastest growing manufacturers of high-reliability electronics for medical, industrial and aerospace & defence applications. With the acquisitio [ … ]
Mon, 16.10.2023
Cicor Technologies Ltd
Bronschhofen, October 16, 2023 – Cicor Technologies Ltd. (SIX Swiss Exchange: CICN) continued on its growth path in the third quarter of 2023. Quarterly sales increased by 22.4% to 95.3 million compared to the third quarter of the previous year (YTD: CHF 294.5 million, increase of 25.0%). Sales growth was driven by accelerated organic growth (11.7% [ … ]
Thu, 12.10.2023
Cicor Technologies Ltd
Cicor Technologies Ltd
/ Key word(s): Partnership
Cicor and Clayens will collaborate to offer one-stop shop solutions for smart drug delivery devices 12.10.2023 / 07:00 CET/CEST
Bronschhofen, October 12, 2023 – The Cicor Group (SIX Swiss Exchange: CICN) announces today that it has signed a Memorandum of Understanding [ … ]
Tue, 25.07.2023
Cicor Technologies Ltd
Bronschhofen, July 25, 2023 - Cicor Group (SIX Swiss Exchange: CICN) continued on its growth path in the first half of 2023 and further increased its operating margin. Net sales grew by 26.2% year-on-year to CHF 199.2 million in the first half of 2023 (1st half 2022: CHF 157.7 million). EBITDA increased by 42% to CHF 21.3 million (1st half 2022: CH [ … ]
Tue, 25.07.2023
Cicor Technologies Ltd
Bronschhofen, July 25, 2023 - Cicor Group (SIX Swiss Exchange: CICN) continued on its growth path in the first half of 2023 and further increased its operating margin. Net sales grew by 26.2% year-on-year to CHF 199.2 million in the first half of 2023 (1st half 2022: CHF 157.7 million). EBITDA increased by 42% to CHF 21.3 million (1st half 2022: CH [ … ]
Wed, 19.04.2023
Cicor Technologies Ltd
Bronschhofen, April 19, 2023 – At yesterday's Annual General Meeting of Cicor Technologies Ltd. (SIX Swiss Exchange: CICN) in Boudry NE, the shareholders approved all proposals.
The Annual General Meeting approved the 2022 annual report, annual financial statements, consolidated financial statements and appropriation of the available earnings. It a [ … ]